| Literature DB >> 31626689 |
Romain Palich1, Marianne Veyri2, Marc-Antoine Valantin1, Anne-Geneviève Marcelin3, Amélie Guihot4, Valérie Pourcher1, Aude Jary3, Caroline Solas5, Alain Makinson6, Isabelle Poizot-Martin7, Dominique Costagliola8, Jean-Philippe Spano2, Christine Katlama1.
Abstract
In 21 cutaneous and/or visceral Kaposi's sarcoma cases, occurring in patients living with human immunodeficiency virus (HIV) who were on antiretroviral therapy with suppressed HIV viremia and high CD4 T cell counts, the efficacy of conventional chemotherapies was limited due to cumulative toxicities, comedications, and a lack of immune improvement.Entities:
Keywords: HIV; Kaposi’s sarcoma; Kaposi’s sarcoma associated herpesvirus; human herpes virus-8
Year: 2020 PMID: 31626689 DOI: 10.1093/cid/ciz762
Source DB: PubMed Journal: Clin Infect Dis ISSN: 1058-4838 Impact factor: 9.079